Gilead Sciences announces executive departure in December

Gilead Sciences Inc. (NASDAQ: GILD) announced that Deborah H. Telman will step down from her role as Executive Vice President, Corporate Affairs and General Counsel effective December 5, 2025.

The company stated that Telman's employment will terminate later in December. The announcement was made on November 19, 2025, according to the press release.

The Delaware-based pharmaceutical company provided no additional details regarding the circumstances of the departure or plans for a replacement in the executive position.

You May Also Be Interested In

• Irenic Capital opposes Independence Realty's Centerspace deal - Bloomberg
• Anthropic Fy25 Gaap Net Loss Expands To $41.97 Bln Vs $8.31 Bln In Fy24, Prospectus Shows - Reuters
• FDA approves Teva's Degevma as biosimilar to Xgeva